Literature DB >> 2570157

A study of familial hypercholesterolaemia in Iceland using RFLPs.

R Taylor1, J Bryant, V Gudnason, G Sigurdsson, S Humphries.   

Abstract

We have studied 17 unrelated families from Iceland who have familial hypercholesterolaemia (FH), using three different restriction fragment length polymorphisms (RFLPs) of the LDL receptor gene. In one family FH was caused by a 2 kb deletion in the LDL receptor gene in the region of exons 9 to 10. The PvuII (intron 15), NcoI (exon 18), and ApaLI (intron 15) RFLPs were used to determine the haplotypes associated with the defective LDL receptor gene in Iceland. Genotypes were determined in 77 subjects from these 17 families, both FH and non-FH. A rare new NcoI RFLP was detected in three subjects. Among the patients, at least four different haplotypes were observed indicating that FH in Iceland is caused by at least four different mutations and is a heterogeneous disease, even in the small, geographically isolated population of Iceland.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570157      PMCID: PMC1015670          DOI: 10.1136/jmg.26.8.494

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor.

Authors:  H Tolleshaug; K K Hobgood; M S Brown; J L Goldstein
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

4.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum.

Authors:  M A Lehrman; W J Schneider; M S Brown; C G Davis; A Elhammer; D W Russell; J L Goldstein
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

6.  Exon-Alu recombination deletes 5 kilobases from the low density lipoprotein receptor gene, producing a null phenotype in familial hypercholesterolemia.

Authors:  M A Lehrman; D W Russell; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

8.  Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains.

Authors:  M A Lehrman; W J Schneider; T C Südhof; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

9.  A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis.

Authors:  S E Humphries; A M Kessling; B Horsthemke; J A Donald; M Seed; N Jowett; M Holm; D J Galton; V Wynn; R Williamson
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

10.  Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1974-07-05       Impact factor: 47.728

View more
  5 in total

1.  European workshop on LDL receptor defects. European Working Group on Familial Hypercholesterolaemia.

Authors:  H Schuster; S Humphries
Journal:  Clin Investig       Date:  1994-11

2.  Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations.

Authors:  A R Miserez; H Schuster; N Chiodetti; U Keller
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

3.  Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia.

Authors:  S Humphries; L King-Underwood; V Gudnason; M Seed; S Delattre; V Clavey; J C Fruchart
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

4.  The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes.

Authors:  Rachel K Putman; Gunnar Gudmundsson; Tetsuro Araki; Mizuki Nishino; Sigurdur Sigurdsson; Elías F Gudmundsson; Gudny Eiríksdottír; Thor Aspelund; James C Ross; Raúl San José Estépar; Ezra R Miller; Yoshitake Yamada; Masahiro Yanagawa; Noriyuki Tomiyama; Lenore J Launer; Tamara B Harris; Souheil El-Chemaly; Benjamin A Raby; Michael H Cho; Ivan O Rosas; George R Washko; David A Schwartz; Edwin K Silverman; Vilmundur Gudnason; Hiroto Hatabu; Gary M Hunninghake
Journal:  Eur Respir J       Date:  2017-09-11       Impact factor: 16.671

5.  Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.

Authors:  Eythór Björnsson; Guðmundur Thorgeirsson; Anna Helgadóttir; Guðmar Thorleifsson; Garðar Sveinbjörnsson; Snaedís Kristmundsdóttir; Hákon Jónsson; Aðalbjörg Jónasdóttir; Áslaug Jónasdóttir; Ásgeir Sigurðsson; Thórarinn Guðnason; Ísleifur Ólafsson; Emil L Sigurðsson; Ólöf Sigurðardóttir; Brynjar Viðarsson; Magnús Baldvinsson; Ragnar Bjarnason; Ragnar Danielsen; Stefán E Matthíasson; Björn L Thórarinsson; Sólveig Grétarsdóttir; Valgerður Steinthórsdóttir; Bjarni V Halldórsson; Karl Andersen; Davíð O Arnar; Ingileif Jónsdóttir; Daníel F Guðbjartsson; Hilma Hólm; Unnur Thorsteinsdóttir; Patrick Sulem; Kári Stefánsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-08-19       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.